The safety profile remains poorly characterized in humans, and no officially recognized clinical use exists
Discuss your medical history with your doctor, especially if you have conditions like heart disease, kidney disease, or any neurological disorders
Neurological Support Potential benefits for brain injuries and nerve damage
GHK-Cu collagen cross-linking and gene modulation require 4 to 8 weeks for visible results
There is evidence that the degree of NP agglomeration also has an effect on the NP exposure, uptake, and distribution in the living tissues, thus influencing the toxicity of NPs (Creutzenberg et al., 2012
10.7150/ijbs.76148 73 MuttenthalerM.KingG